Fundraising Fox

Bluevia Health

Entrepreneur First '25

London, GB · Founded 2025 · 3 known investors

blueviahealth.com

Bluevia Health provides an AI system that automates pre-admission (pre-op) workflows for surgical teams, placing patient calls in multiple languages, pulling data from EMRs, flagging clinical risks, and preparing charts for clinician review and sign-off. It targets hospitals and health systems in the United States, integrating with EMRs such as Epic, athenahealth, HST, and Surgical Information Systems.

Also known as Bluevia

AI & Machine LearningDigital HealthHealthtech

Founders & leadership

Bluevia Health was founded in 2025 by Ali Mahomed and Abhyuday Roychowdhury.

AM
Ali MahomedinCEOAli Mahomed is a serial healthcare entrepreneur who left his studies at Cambridge to build companies. He joined ATAI early and stayed through its $2 billion Nasdaq listing, and later co-founded Heading Health, a Thiel Capital–backed company that has become one of the largest ketamine treatment providers in the United States.
ARAbhyuday Roychowdhury
Abhyuday RoychowdhuryinCTO & Co-FounderAbhyuday Roychowdhury is an applied AI engineer whose career includes stints at Twitter and Yelp. While at Yelp, he built the company's first autonomous lead system, which handled thousands of leads monthly and brought in six figures of revenue.

Investors · 3

Also in the syndicate · 2

angel investors including co-founders of Anterior and Datavant and a former Board Member of Mass General BrighamAtlas AI VB Fundlead

Company profile

researched Aug 2026

Bluevia Health offers an autonomous pre-operative (pre-admission) system for surgical care. According to the company's website, the product runs pre-admission end to end: it places calls to every patient in the patient's own language, pulls data from any EMR, flags clinically relevant risks, and returns a prepared chart to the care team, with a clinician always reviewing and signing off. An illustrative example on the site shows the system detecting that a patient had taken the anticoagulant Eliquis and flagging a five-day hold before surgery, alongside other pre-op checks such as NPO status and transport. The system is described as integrating with Epic, athenahealth, HST, Surgical Information Systems and other EMRs, and writing a completed chart back into the source system.

The company frames its longer-term ambition as an "operating system for procedural care." A May 2026 article describes Bluevia as a clinical intelligence platform and workflow operating system covering the full arc of the perioperative journey — before, during, and after surgery — and notes work on detecting postoperative deterioration earlier. The same article situates the company against the burden of surgical complications, citing an estimated 160,000-300,000 surgical site infections annually in the US, SSIs accounting for roughly 20% of hospital-acquired infections, doubled mortality risk, roughly 10 additional hospital days and at least $20,000 in added cost per SSI patient, and roughly one in five surgical patients globally experiencing a post-operative complication.

An investor directory classifies Bluevia Health in the healthcare and digital health sector, at seed stage, with a B2B SaaS business model.

Founding story

Sources report that Ali Mahomed left the University of Cambridge to work in startups and co-founded Heading Health, a network of insurance-covered psychedelic clinics that scaled to eight figures in annual recurring revenue with backing from Thiel Capital. The decision to start Bluevia followed a personal experience: Mahomed's uncle suffered a severe complication after a routine surgery, which reshaped his view of perioperative care. He reportedly spent months observing operating rooms and back offices before any code was written, then assembled a team of clinicians, operators, and engineers.

Business model

Bluevia Health is categorized as B2B SaaS, selling to hospitals, health systems, and surgical care providers rather than to patients. The product is positioned as a service that takes over pre-admission work for surgical teams and connects into the customer's existing EMR, writing a completed chart back to that system. The website quantifies the value proposition for buyers in terms of recovered revenue from prevented case cancellations, reduced day-of cancellations, and nursing hours returned per day.

Described by a startup directory as B2B SaaS. The website frames buyer economics as revenue uplift from recovered cancelled OR time (estimated at about $2,000 per prevented cancellation, and $1M+ per year at scale across a health system), roughly 30% fewer day-of cancellations, and about six hours of nurse time returned per day; pricing is not disclosed in the sources.

Traction

Selected as one of 18 companies in the 2026 Mayo Clinic Platform_Accelerate cohort, a 30-week program providing access to de-identified longitudinal clinical records and Mayo Clinic Platform clinicians. Reported to be piloting with surgical care providers across the US as of May 2026. Named investors include Atlas AI VB Fund, Overlook Ventures, AI Seed, Rock Yard Ventures, and Entrepreneur First. No customer counts, revenue, or headcount figures are disclosed in the sources.

Latest developments

March 2026: selected for the 2026 Mayo Clinic Platform_Accelerate cohort (18 companies), with press coverage of the cohort's access to de-identified clinical records. May 2026: press profile describing an announced pre-seed round led off by Atlas AI VB Fund with Overlook Ventures, AI Seed, Rock Yard Ventures and healthcare angels, US pilots underway, and a roadmap toward a perioperative workflow operating system and international expansion.

Full profile — market position, technology, go-to-market, geography, history, risks & controversies

Market position

Bluevia Health is an early-stage (seed/pre-seed) entrant positioned in perioperative clinical AI, targeting surgical complications and pre-admission workflow automation. Its participation in the Mayo Clinic Platform_Accelerate program is presented by the company and by press coverage as a source of clinical data access and validation credibility. A startup directory lists other healthcare and digital health companies including Orchestra Health, patients.app, Proximie, Uncovr, and Eka.care as similar companies, though not explicitly as competitors.

The company positions itself around end-to-end autonomy of the pre-admission process with a clinician sign-off step retained, multilingual patient calling, and write-back into existing EMRs rather than a standalone system. Founders emphasize designing for clinician users rather than buyers, and building from a measurable clinical and economic problem. Advisory bench includes patient-safety figure Dr. Peter Pronovost and clinical and quality advisors.

Technology

An AI system that conducts automated multilingual patient phone calls for pre-admission assessment, ingests data from EMRs, identifies clinical risks such as anticoagulant use requiring a medication hold, and generates a chart for clinician review and sign-off. Stated EMR integrations include Epic, athenahealth, HST, and Surgical Information Systems. The company also describes work on complication detection and earlier identification of postoperative deterioration, being built and validated using Mayo Clinic Platform's de-identified longitudinal clinical records, described as including over 15.1 million patient records, 1.65 billion clinical notes, and 12 billion radiology images.

Go-to-market

Direct enterprise sales to surgical providers, with the website's primary calls to action being to book a demo and to connect Bluevia to the customer's EMR. As of May 2026 the company was piloting with surgical care providers across the US. The team includes dedicated go-to-market staff and a GTM advisor who previously led business development at Google Health.

Hospitals, health systems, and surgical care providers in the United States, with a stated longer-term roadmap into hospitals and health systems globally, including European markets. The buyers and users described are surgical teams, pre-op nurses, and clinicians responsible for pre-admission assessment.

Geography

Commercial focus on the United States, where the company reports pilots with surgical care providers; press coverage describes ambitions to scale globally, including into European markets. Team backgrounds and the CTO's NHS work indicate UK ties.

History

The company was co-founded by Ali Mahomed (CEO) and Abhyuday Roychowdhury (CTO). It raised a pre-seed round with Atlas AI VB Fund writing the first check, alongside Overlook Ventures, AI Seed, Rock Yard Ventures, and angel investors including co-founders of Anterior and Datavant and a former board member of Mass General Brigham. In March 2026 Bluevia Health was named one of 18 companies in the 2026 Mayo Clinic Platform_Accelerate cohort. By May 2026 the company was reported to be piloting with surgical care providers across the United States.

Risks & controversies

Sources disclose no controversies. Notable uncertainties visible in the material: the company is early stage with pilots rather than disclosed production customers; the quantified benefit figures on its website are estimates extrapolated from third-party literature (Turunen et al., 2018; Cureus, 2025) rather than measured customer outcomes; and no funding amount, revenue, or customer numbers are publicly stated.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Disclosed investors listed on F4 profileJan 20262 investors
Estimated annual revenue uplift at scale (vendor estimate)Jan 2026$1M
Mayo Clinic Platform Accelerate cohort sizeMar 202618 companies
Nurse time returned per day (vendor estimate)Jan 20266 hours per day
Reduction in day-of surgical case cancellations (vendor claim)Jan 202630%
StageJan 2026Seed

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Timeline · 3

launches, deals, and filings
May 2026
Pre-seed round with Atlas AI VB Fund writing the first check

Atlas AI VB Fund General Partner Matteo Confalonieri wrote the first check into Bluevia Health's pre-seed round, joined by Overlook Ventures, AI Seed, Rock Yard Ventures, and angels including co-founders of Anterior and Datavant and a former Mass General Brigham board member. Amount not disclosed.

source ↗

May 2026
Pilots underway with US surgical care providers

Reported to be piloting its perioperative workflow platform with surgical care providers across the United States, with ambitions to scale globally.

source ↗

Mar 2026
Selected for 2026 Mayo Clinic Platform_Accelerate cohort

Bluevia Health was one of 18 companies chosen for the 2026 Mayo Clinic Platform_Accelerate cohort, a 30-week program pairing startups with Mayo Clinic Platform clinicians and millions of de-identified, longitudinal clinical records to build and validate AI.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Bluevia Health do?
Bluevia Health builds an autonomous pre-operative AI system that runs pre-admission workflows for surgical teams.
Who founded Bluevia Health?
Bluevia Health was founded by Ali Mahomed, Abhyuday Roychowdhury in 2025.
Who are Bluevia Health's investors?
Bluevia Health's investors include Entrepreneur First.
Where is Bluevia Health headquartered?
Bluevia Health is headquartered in London, GB.